Related references
Note: Only part of the references are listed.EphB3 Is Overexpressed in Non-Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration
Xiao-Dan Ji et al.
CANCER RESEARCH (2011)
Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness
X. He et al.
ONCOGENE (2011)
Optimization of genetics to create therapies for metastatic (stage IV) non-small-cell lung cancer
Rafael Rosell et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells
Jonathan W. Astin et al.
NATURE CELL BIOLOGY (2010)
A New α5β1 Integrin-Dependent Survival Pathway Through GSK3β Activation in Leukemic Cells
Fabienne De Toni-Costes et al.
PLOS ONE (2010)
A Crucial Role for RACK1 in the Regulation of Glucose-Stimulated IRE1α Activation in Pancreatic β Cells
Yifu Qiu et al.
SCIENCE SIGNALING (2010)
EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
Hui Miao et al.
CANCER CELL (2009)
Curcumin Disrupts the Mammalian Target of Rapamycin-Raptor Complex
Christopher S. Beevers et al.
CANCER RESEARCH (2009)
Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells
Sou-Tyau Chiu et al.
CARCINOGENESIS (2009)
Dissociation of EphB2 Signaling Pathways Mediating Progenitor Cell Proliferation and Tumor Suppression
Maria Genander et al.
CELL (2009)
Eph-ephrin bidirectional signaling in physiology and disease
Elena B. Pasquale
CELL (2008)
PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail)
Veerle Janssens et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone
Saburo Sone et al.
CANCER AND METASTASIS REVIEWS (2007)
iTARGET: A phase II trial to assess the response to gefitinib in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) tumors
L. V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints
V. Mamidipudi et al.
ONCOGENE (2007)
Paradoxes of the EphB4 receptor in cancer
Nicole K. Noren et al.
CANCER RESEARCH (2007)
Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers
Yan Wang et al.
CANCER RESEARCH (2007)
Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway
Nicole K. Noren et al.
NATURE CELL BIOLOGY (2006)
Receptor tyrosine kinase EphB4 is a survival factor in breast cancer
S. Ram Kumar et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and β1 integrin to promote cell migration
Patrick A. Kiely et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
EphB/EphrinB receptors and Wnt signaling in colorectal cancer
H Clevers et al.
CANCER RESEARCH (2006)
A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis
W Bin Fang et al.
ONCOGENE (2005)
Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes
CS Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of EphA4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function
J Egea et al.
NEURON (2005)
EphB receptor activity suppresses colorectal cancer progression
E Batlle et al.
NATURE (2005)
EPH receptor signalling casts a wide net on cell behaviour
EB Pasquale
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics
RC Ireton et al.
CURRENT CANCER DRUG TARGETS (2005)
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer
P Huusko et al.
NATURE GENETICS (2004)
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways
R Sordella et al.
SCIENCE (2004)
Regulation of eukaryotic translation by the RACK1 protein: a platform for signalling molecules on the ribosome
J Nilsson et al.
EMBO REPORTS (2004)
Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation
YN Rui et al.
EMBO JOURNAL (2004)
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1
LW Noblitt et al.
CANCER GENE THERAPY (2004)
Identification of the versatile scaffold protein RACK1 on the eukaryotic ribosome by cryo-EM
J Sengupta et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A
LK Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The RACK1 scaffold protein: A dynamic cog in cell response mechanisms
A McCahill et al.
MOLECULAR PHARMACOLOGY (2002)
Mechanisms and functions of EPH and ephrin signalling
K Kullander et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death
PA Kiely et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The anchoring protein RACK1 links protein kinase Cε to integrin β chains -: Requirement for adhesion and motility
A Besson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
A Bhattacharjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Structural basis for autoinhibition of the EphB2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region
LE Wybenga-Groot et al.
CELL (2001)
Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses
AH Zisch et al.
ONCOGENE (2000)
Share Paper
